Thomas Carella Net Worth & Insider Trades
Thomas Carella T2 Biosystems, Inc
What is Thomas Carella's Net Worth?
The current estimated net worth of T2 Biosystems, Inc's Thomas Carella is estimated to be about $1.04B . Thomas Carella owns about 4,157,240 units of T2 Biosystems, Inc common stock. In the last year at T2 Biosystems, Inc, Thomas Carella has sold an estimated value of $0 worth.
What is Thomas Carella's Past Insider Trading?
Thomas Carella's largest purchase order was 3,457,240 units , worth over $10M on August 14, 2014. In total, Thomas Carella has made about 3 transactions over a year of their time at T2 Biosystems, Inc. Thomas Carella usually trades in December, August and June, with the busiest year in 2015. The most recent transaction was a purchase order of 700,000 units , worth over $6.83M on December 11, 2015.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
THOMAS CARELLA
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Thomas Carella's' Mailing Address?
- Mailing address is C/o Goldman, Sachs & Co. 85 Broad Street New York NY 10004 NY
T2 Biosystems, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| John Sperzel, | 2020 | $490,705 | - | - | $2,571,384 | $393,750 | $3,000 | $3,458,839 |
| John McDonough, | 2020 | $72,906 | - | $74,999 | - | - | $1,022,182 | $1,170,087 |
| John McDonough, | 2019 | $550,000 | - | $372,000 | $478,728 | $233,750 | $3,000 | $1,637,478 |
| Alec Barclay, | 2020 | $340,000 | - | $25,675 | $38,621 | $234,600 | $952 | $639,848 |
| Alec Barclay, | 2019 | $337,500 | $35,000 | $111,600 | $348,834 | $102,000 | $2,900 | $937,834 |
| Anthony Pare, | 2020 | $325,000 | - | $20,738 | $159,763 | $185,250 | $3,000 | $693,751 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1492674/000119312521161531/d23237ddef14a.htm
What are T2 Biosystems, Inc's Past Insider Trades?
T2 Biosystems, Inc's most recent insider trade came on September 22, 2023 by CR Group Lp, Crg Partners Iii Lp, Crg Partners Iii Parallel Fund A Lp, Crg Partners Iii Cayman Unlev Aiv I Lp and Crg Partners Iii Cayman Lev Aiv I Lp who sold 7,753,710 units worth $2.41M . In the last 9 years, insiders at T2 Biosystems, Inc have sold an estimated value of $15.31M and bought an estimated value of $60.75M worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Thomas Lowery, Chief Scientific Officer, Terrence Michael Gibbs, General Counsel, and David Elsbree, Director .
T2 Biosystems, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||